0% found this document useful (0 votes)
90 views66 pages

Drug Receptors

The document provides an overview of various types of receptors involved in drug interactions, including ligand-gated ion channels, G-protein coupled receptors, kinase-linked receptors, and nuclear receptors. It discusses the mechanisms of drug-receptor interactions, classification of receptors, and their roles in physiological processes. The conclusion emphasizes the need for further research to discover new receptor types and improve drug targeting for disease treatment.

Uploaded by

Anas
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
90 views66 pages

Drug Receptors

The document provides an overview of various types of receptors involved in drug interactions, including ligand-gated ion channels, G-protein coupled receptors, kinase-linked receptors, and nuclear receptors. It discusses the mechanisms of drug-receptor interactions, classification of receptors, and their roles in physiological processes. The conclusion emphasizes the need for further research to discover new receptor types and improve drug targeting for disease treatment.

Uploaded by

Anas
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

CONTENTS

 Introduction - receptor
 Drug – receptor interactions
 Ligand gated ion channel receptors

 G – protein coupled receptors

 Kinase liked receptors

 Nuclear receptors

 Comparison of receptor types

 Conclusion

 References
RECEPTOR?
 Paul Ehrlich

 Specialized areas of cell to


which drugs get
bound.

 They are regulatory protein macro


molecules .

 drug should have –selectivity to a


receptor ; receptor should have - ligand
specificity to elicit action.
DRUG RECEPTOR
INTERACTIONS
 Effect of drug attributed to two factors

t Affinity : tendency of the drug to bind


to receptor and form D-R complex .

mEfficacy or intrinsic activity : ability of the


drug to trigger pharmacological responses
after forming D-R complex .
CONTD…

 Based on affinity and intrinsic activity :


 Full agonist : high affinity

high intrinsic activity(=1)


Eg. Methacholine on acetylcholine receptors

Antagonist : only affinity


no intrinsic activity (=0)
Eg. Atropine on muscarinic receptors
Natura Natural

Enhanced
cell ar

Natura
CONTD..

Partial agonist: full affinity


intrinsic activity <1 (0 to 1)
Eg. Naloxene on opioid receptors
saralasin on angiotensin
receptors

 Inverse agonist: full affinity


intrinsic activity<0(0 to-1)
Eg. Beta carbolines on BZP receptor.
E

. 0.1 1.0 la.a .


(0tf8h\l£ll9h Otcrpang
0l/1)
(m|l
é Elp/é
CLASSIFICATION -
IUPHAR
Cell surface Intracellular
1. Inotropic. 1. Nuclear
receptors .
3. Metabotropic.

5. Ligand regulated
trans membrane.

Also called ionotropic receptors.


involved mainly in fast
synaptic transmission.

Eg: nAchR, GABAA, and


glutamate
receptors of the NMDA, AMPA
and kainate types.
FEATURES – ION
CHANNELS

 Protein molecules form water


filled pores that span the
membrane.

 Switch between open and


closed
states.

 Rate and Direction of movement


depends on
electrochemical gradient
of the ions
STRUCTURE

 ligand binding site in


extracellular domain.
 5 subunits 2α, β, γ and δ.

 α2, β, γ - pentameric str - 2


ligand binding sites

 Each subunit spans the membrane 4


times; all subunits form a central pore.
Ligand
binding
site
Cell Membrane

Ion Chan nel


0

ion channel receptor

a r>pec <>g>
t r>
e e < r>o r>r> eI
io sta
/l O *e’y* LE“hI0 I E“c& C D I I
GATING MECHANISM IN
GABA A RECEPTOR
CONTD.
 Due to the concentration changes of
different ions the following effects are
seen.

 Increase in Na and Ca levels- excitatory


 Decrease in Na and Ca levels- inhibitory

 Increase in K levels – inhibitory


 Decrease in K levels – excitatory

 Increase in Cl levels – inhibitory


 Decrease in Cl levels- excitatory
IMPORTANCE
 Generation , propagation of nerve impulse.

 Synaptic transmission of neurons.

 Muscle contraction.

 Salt balance.

 Hormone release.

 Muscle relaxants , anti-arrhythmatics


,anesthetics – act by blocking ion channels.
 metabotropic or 7-
transmembrane- spanning
(heptahelical) receptors.

 coupled to intracellular effector


systems via a G-protein.

 mAChRs, adrenoceptors,
dopamine, 5- HT, opiate, peptide,
purinoceptors, orphans .
STRUCTURE
GPCR
3 families:
 A – rhodopsin family
eg. Amine NT, purines , cannabinoids

 B - secretin/glucagon receptor

family Eg. Peptide hormones.

 C - metabotropic glutamate
receptor/calcium sensor
family.
Eg. GABAB , Glutamate.
-ROLE
 Membrane resident proteins –
recognize activated GPCRs- pass
message to effector system.

 Occurs in interaction with guanine


nucleotides ; freely moving in cytoplasm.
 α, β and γ subunits – trimer in resting state.

 3 subunits attached to GPCR through


fatty acid chain – reaction called
prenylation.
SUBTYPES
G-PROTEIN RECEPTOR FOR SIGNALLING
PATHWAY
GS Beta adrenergic Adenylyl cyclase
amines, glucagon
histamine, serotonin CAMP

Excitatory effects
Gi1, Gi2, Alpha2 adrenergic adenylyl cyclase
Gi3 amines, mAchR, CAMP
opioid, Cardiac K+
serotonin channel open-
heart rate
Olfactory epithelium Adenylyl cyclase
Golf –
CAMP
G- RECEPTOR SIGNALLING
PROTEIN FOR PATHWAY
GO NT ,Opioid Not clear
cannabinoid
Gq mAchR, PLC
serotonin IP3 , DAG
5HT1C Cytoplasmic Ca
Gt1 , Gt2 Rhodopsin
and colour cGMP
opsins in phosphodiesteras
retinal rod e- cGMP
and cone cells
SYSTEMS INVOLVED IN
SIGNAL TRANSDUCTION


The adenyly cyclase / cAMP system


The Phospholipase C /
inositol phosphate system


The Ion channels


The Rho A /Rho kinase system
ADENYLYL CYCLASE/
CAMP SYSTEM
 c AMP –nucleotide synthesized from ATP -
by adenylyl cyclase, metabolized by
PDE.

 Regulate enzymes of metabolism,


growth, contractile proteins of muscle.

 NT - acts on GPCR –Gs/Gi activated - produce


effects – by inc or dec. activity of adenylyl cylase-
and cAMP.
 c AMP- activate - Protein
kinases-activate/inactivate enzymes by
phosphorylation – cellular events.
PHOSPHOLIPASE
C-
INOSITOL SYSTEM
 Phospholipase C : Cleaves
membrane phospholipids -
phosphoinositides.

 PLC beta – cleaves


phosphatidylinositol(4,5)bis Phosphate PIP2
- into DAG and IP3.
 DAG and IP3 - Secondary messenegers –
elicit cellular responses.
ION CHANNELS
 GPCR- directly control ion channel-without secondary
messenger. Eg. mAchR in heart – activate K+
channel.
SYSTEM
 Involved in growth, proliferation,
differentiation or survival-called growth factors.

 Mediate actions of protein mediators-


GF, cytokines , harmones- insulin and
leptin.

 Slow – require the expression of new genes.

 Single membrane spanning helix - extracellular


ligand binding domain - intracellular domain.
Structure of Kinases linked
receptors
Extracellular domain
Binds to the ligand (growth factor)

Trans membrane domain

Y
Y
Intracellular domain
Y
Endogenous kinases
Y bind
Y
and get phosphorlated
Y
TYPES

receptor tyrosine kinases
Eg. EGF , NGF , insulin receptor


serine/ threonine kinases
Eg. TGF


cytokine receptors
Eg. Cytokines ,
CSF

guanylyl cyclase receptors
Eg. ANP
Gene
transcriptio Kinase cascade
n
 Important pathways activated :

1. The Ras/Raf/mitogen- activated protein


(MAP) kinase pathway
- activated by tyrosine kinases.
- important in cell division,
growth, differentiation.

2. The Jak/Stat pathway


- activated by cytokines.
-controls synthesis and release of
inflammatory mediators.
 Ligand activated transcription factors.

 Present in soluble form – either in cytoplasm


or nucleus – freely diffusable.

 Transduce signals by- modifying gene transcription.

 Eg: steroid hormones, glucocorticoids, vit D and


A, orphan receptors
 Play vital role in endocrine signaling and
metabolic regulation.
AF2

AF1
-Binds with
corepressor
Zn fingers;hor
response
elements
Class I Hybrid Class II
class
Present Mainly Present in nucleus
in endocrine
cytoplasm •
Form •
Form hetero

Form homodimers hetero dimers with

Mainly endocrine; dimers with RXR

Associated with RXR •
Mainly lipids
heat shock •
Associated with
proteins. co-repressor
proteins.
High affinity Low
binding affinity
binding
GR, MR, ER, PR, TR, PPAR, LXR, FXR,
AR VDR, RXR
RAR
CLASS - I

homo

HRE-
hormone
response
elements
CLASS II
COMPARISON OF RECEPTORS
TYPES
INOTROPIC METABOTRO KINASE NUCLEAR
PIC LINKED

NO.OF
FAMILIES 483 217 135 4
8
LOCATIO
N MEMBRAN MEMBRANE MEMBRANE
E INTRACELLULA
R

TIME MILLI SECONDS HOURS HOURS


SCALE SECONDS

COUPLIN S DIRECT GABAA VIA


G G-PROTIEN

EXAMPLE nAchR, ADRENOCEP


TORS, DIR VIA DNA
mAchR ECT

STEROIDS
INSULI
N
CYTOKI
NES GF
CONCLUSION
 Extensive research done on Receptor
pharmacology
-lead to discovery of new drug targets for
treatment of several diseases.

 Still requires discovery of new receptor types


and the mechanisms of many orphan receptors
that can result in effective treatment of many
diseases.

 Requires development of receptor


crystallization etc.
 Much to be discovered about the nuclear
receptors.
REFERENCES
 Rang , Dale, Ritter ,Flower :Rang and
Dale’s pharmacology;6th edition,
Churchill Livingstone;2008, 9-52.
 Bertram G.Katzung : Basic and
clinical pharmacology; 10th
edition;2006.
 KD Tripati: essentials of medical
pharmacology ; 6th edition; 2008,
40-52.

You might also like